Innoviva, Inc.
INVA
$22.12
-$0.74-3.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 186.85M | 174.85M | 144.42M | 128.97M | 128.72M |
| Total Other Revenue | 233.84M | 236.48M | 244.10M | 241.26M | 241.13M |
| Total Revenue | 420.69M | 411.33M | 388.52M | 370.23M | 369.84M |
| Cost of Revenue | 96.92M | 91.06M | 63.95M | 39.96M | 37.84M |
| Gross Profit | 323.77M | 320.27M | 324.57M | 330.27M | 332.00M |
| SG&A Expenses | 118.34M | 113.39M | 112.68M | 111.53M | 112.86M |
| Depreciation & Amortization | 26.36M | 26.28M | 26.15M | 26.04M | 25.94M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 254.84M | 243.11M | 215.16M | 189.91M | 183.59M |
| Operating Income | 165.85M | 168.22M | 173.36M | 180.32M | 186.25M |
| Income Before Tax | 600.01M | 326.86M | 156.52M | 65.55M | -46.33M |
| Income Tax Expenses | 95.67M | 55.70M | 29.18M | 26.90M | 13.40M |
| Earnings from Continuing Operations | 504.34 | 271.17 | 127.34 | 38.65 | -59.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 504.34M | 271.17M | 127.34M | 38.65M | -59.72M |
| EBIT | 165.85M | 168.22M | 173.36M | 180.32M | 186.25M |
| EBITDA | 192.34M | 194.63M | 199.64M | 206.48M | 212.30M |
| EPS Basic | 7.03 | 3.77 | 1.90 | 0.61 | -0.95 |
| Normalized Basic EPS | 1.56 | 1.59 | 1.70 | 1.78 | 1.81 |
| EPS Diluted | 6.01 | 3.06 | 1.39 | 0.33 | -1.00 |
| Normalized Diluted EPS | 1.28 | 1.36 | 1.39 | 1.54 | 1.69 |
| Average Basic Shares Outstanding | 280.88M | 269.43M | 257.26M | 250.77M | 250.43M |
| Average Diluted Shares Outstanding | 339.53M | 317.39M | 316.33M | 294.31M | 272.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |